Regulus Therapeutics Inc. (RGLS) Share-based Payment Arrangement, Expense USD 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Regulus Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2024.
  • Regulus Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $985 K, a 140% increase year-over-year.
  • Regulus Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $3.38 M, a 113% increase year-over-year.
  • Regulus Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.8 M, a 28.7% increase from 2022.
  • Regulus Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.18 M, a 25.5% decline from 2021.
  • Regulus Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.92 M, a 11.8% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.38 M $985 K +$575 K +140% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.8 M $1.04 M +$640 K +162% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $2.16 M $973 K +$613 K +170% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.55 M $382 K -$39 K -9.26% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.59 M $410 K -$590 K -59% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.18 M $396 K -$275 K -41% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $2.45 M $360 K -$447 K -55.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $2.9 M $421 K -$333 K -44.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3.23 M $1 M +$309 K +44.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $2.92 M $671 K +$201 K +42.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $2.72 M $807 K +$115 K +16.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.61 M $754 K +$125 K +19.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $2.48 M $691 K -$132 K -16% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $2.61 M $470 K -$4 K -0.84% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $2.62 M $692 K +$156 K +29.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $2.46 M $629 K +$310 K +97.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $2.15 M $823 K -$136 K -14.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $2.29 M $474 K -$1.58 M -76.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 $3.87 M $536 K +$136 K +34% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $3.73 M $319 K -$1.04 M -76.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $4.77 M $959 K -$668 K -41.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $5.44 M $2.06 M +$944 K +84.9% Oct 16, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $400 K -$884 K -68.8% Oct 15, 2018 10-K 2020-03-12
Q3 2018 $4.5 M $1.39 M +$106 K +8.26% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $5.38 M $1.36 M -$1.51 M -52.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $6.89 M $1.63 M -$754 K -31.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $7.64 M $1.11 M -$2.31 M -67.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $9.95 M $1.28 M -$2.18 M -63% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $12.1 M $2.87 M +$627 K +28% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $11.5 M $2.38 M -$1.37 M -36.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $12.9 M $3.42 M -$344 K -9.14% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 $13.2 M $3.47 M +$833 K +31.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $12.4 M $2.24 M -$3.63 M -61.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $16 M $3.75 M +$646 K +20.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $15.4 M $3.76 M +$1.43 M +61.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 $13.9 M $2.63 M +$1.01 M +61.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $12.9 M $5.87 M +$4.19 M +249% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 $8.74 M $3.1 M +$1.7 M +122% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 $7.04 M $2.33 M +$1.43 M +159% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-03
Q3 2014 $5.61 M $1.63 M +$649 K +66.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $4.96 M $1.68 M +$925 K +122% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $4.04 M $1.4 M +$613 K +77.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $3.42 M $898 K +$80 K +9.78% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-23
Q3 2013 $3.34 M $978 K +$564 K +136% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $2.78 M $759 K +$554 K +270% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $2.22 M $787 K +$674 K +596% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $1.55 M $818 K Oct 1, 2012 Dec 31, 2012 10-K 2015-02-19
Q3 2012 $414 K +$218 K +111% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $205 K Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-08-16
Q1 2012 $113 K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 $196 K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.